Morton's Neuroma Clinical Trial
Official title:
A Randomised, Double-blind, Placebo-controlled, Three-way Cross-over Single Center Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)
To characterize the phenotype in patients with Morton's neuroma and to explore the effect of local administration of Xylocaine (lidocaine)
A randomised, double-blind, placebo-controlled, three-way cross-over single center study to characterize the phenotype in patients with Morton's Neuroma and to explore the effect of local administration of Xylocaine (lidocaine) ;
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03940963 -
Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain
|
N/A | |
| Recruiting |
NCT05695339 -
Resiniferatoxin for the Management of Refractory Morton s Neuroma Pain
|
Phase 1 | |
| Recruiting |
NCT00284583 -
Comparison of Alcohol and Steroid Injection for Treating Morton's Neuroma
|
N/A | |
| Completed |
NCT02550756 -
Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
|
Phase 1 | |
| Completed |
NCT02678793 -
A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
|
Phase 2 | |
| Active, not recruiting |
NCT05604144 -
Cryoanalgesia for the Treatment of Pain in Subjects With Morton's Neuroma
|
N/A |